Bristol-Myers Squibb is trading 4.2% down at $56.88 following a broad pullback in healthcare names.
- Shares are on pace for their largest percentage decline since July 2025, according to intraday trading data.
- The drop appears tied to sector pressure and risk-off sentiment rather than any fresh, company-specific news or guidance changes.